Filing Details
- Accession Number:
- 0001209191-11-021761
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-04-05 17:34:36
- Reporting Period:
- 2011-04-01
- Filing Date:
- 2011-04-05
- Accepted Time:
- 2011-04-05 17:34:36
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1088856 | Corcept Therapeutics Inc | CORT | Pharmaceutical Preparations (2834) | 770487658 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1286208 | L Robert Roe | C/O Corcept Therapeutics 149 Commonwealth Drive Menlo Park CA 94025 | President And Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2011-04-01 | 15,000 | $4.24 | 53,890 | No | 4 | S | Direct | |
Common Stock | Disposition | 2011-04-04 | 10,000 | $4.23 | 43,890 | No | 4 | S | Direct | |
Common Stock | Disposition | 2011-04-05 | 5,000 | $4.21 | 38,890 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The sale is made pursuant to terms of a 10b5-1 plan in effect at the time of sale of the shares.
- Represents the weighted average sale price for the entire number of shares sold. The sale prices range from $4.23 to $4.25 per share. Full information on the numbers of shares sold at each sale price is available upon request.
- Represents the weighted average sale price for the entire number of shares sold. The sale prices range from $4.20 to $4.24 per share. Full information on the numbers of shares sold at each sale price is available upon request.